Palanca, A., Ampudia-Blasco, F., Calderón, J., Sauri, I., Martinez-Hervás, S., Trillo, J., . . . Real, J. (2024). Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study.
Citación estilo ChicagoPalanca, A., FJ Ampudia-Blasco, JM Calderón, I. Sauri, S. Martinez-Hervás, JL Trillo, J. Redón, y JT Real. Comparison of GLP-1 Receptor Agonists and Other Glucose-Lowering Agents On Cardiovascular Outcomes in Individuals With Type 2 Diabetes and Obesity: A Spanish Real-World Population-Based Study. 2024.
Cita MLAPalanca, A., et al. Comparison of GLP-1 Receptor Agonists and Other Glucose-Lowering Agents On Cardiovascular Outcomes in Individuals With Type 2 Diabetes and Obesity: A Spanish Real-World Population-Based Study. 2024.